Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2011; Volume 203, Supplement 686
Joint Congress of FEPS and Turkish Society of Physiological Sciences
9/3/2011-9/7/2011
Istanbul, Turkey


MOLECULAR ANALYSIS OF SMAD-1, BMP-2, BCL-XL AND CASPASE-3 GENES IN RENAL ISCHEMIA-REPERFUSION MODEL IN RATS
Abstract number: PC024

Bulut1 Ahmed, Demir1 Tuncer, Cengiz1 Beyhan, Tutar2 Ediz, Oztuzcu3 Serdar, Yasir Bahar2 Abdulkadir, Demiryurek1 [Scedil]eniz, Dusmez1 Duygu, Nur Dagli1 [Scedil]eyda, Bagci1 Cahit

1Department of Physilogy, Gaziantep University, Gaziantep, Turkey
2Department of Pathology, Gaziantep University, Gaziantep, Turkey
3Department of Medical Biology, Gaziantep University, Gaziantep, Turkey

Objective: 

In this study, we aimed to investigate the effects of Smad-1 (TGF super family) and BMP-2 genes in renal Ischemia-Reperfusion (I/R) model in rats. Furthermore, we aimed to investigate the gene levels of Caspase-3 (affected by apoptotic) and Bcl-xL (affected by antiapoptotic) genes to find out the possible apoptotic effects of Smad1 and BMP2 in the kidney.

Methods: 

Forty female rats were allocated into sham, ischemia, ischemia+Ca channel blocker and ischemia+Na channel blocker groups. The ischemia group did not receive any treatment. Other groups received Ca channel blocker or Na+ channel blocker before 30 minutes of anesthesia. Then, the abdomen was opened with a midline incision and bilateral renal arters were clamped for 60 minutes. After 48 hour reperfusion, blood samples and kidney tissues were collected. Tissue samples were examined by histopathological and RT-PCR methods for the expression levels of Smad-1, Bmp-2, Bcl-xL and Caspase-3.

Results: 

There was a significant histopathologial difference between the calcium channel blocker group and other groups. On the other hand, Bcl-xL gene was significantly different from Smad-1, Bmp-2 and Caspase-3 genes according to the moleculer analyses.

Conclusions: 

Calcium channel blockers may ameliorate the renal ischemia-reperfusion injury. These agents may be beneficial after controlled clinical studies.

To cite this abstract, please use the following information:
Acta Physiologica 2011; Volume 203, Supplement 686 :PC024

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE